*Department of Health Policy and Management
†Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
‡Carevive Systems Inc., Philadelphia, PA
§Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC
This paper is part of the PRO-cision Medicine Methods Toolkit paper series funded by Genentech. The PRO-cision Medicine Methods Toolkit paper series was presented during a symposium at the 2018 Annual Conference of the International Society for Quality of Life Research, Dublin, Ireland.
Research reported in this publication was partially funded through a Patient-Centered Outcomes Research Institute (PCORI) Award (IHS-1511-33392). This work is solely the responsibility of the authors and does not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors, or Methodology Committee. Additional funding sources include K07 CA124851, Carevive Systems Inc., Celgene, Takeda Pharmaceuticals, and Millennium. The University of North Carolina’s Patient-Reported Outcomes Core is supported in part by the University Cancer Research Fund and the Lineberger Comprehensive Cancer Center core grant (P30-CA-016086).
Portions of this work were presented at the 2018 ASCO quality of care symposium and the 2018 International Society for Quality of Life research conference (Dublin, Ireland, October 25–27, 2018).
A.M.S: honorarium from Genentech. C.T.S.: Stockholder and Officer, Carevive Systems Inc., honorarium from Genentech for paper contribution, honorarium from role on PRO-Cision Medicine Methods Toolkit Steering Committee. K.H.: stockholder and employee, Carevive Systems Inc. The remaining authors declare no conflict of interest.
Reprints: Angela M. Stover, PhD, Department of Health Policy and Management, University of North Carolina at Chapel Hill, 1103-D McGavran-Greenberg Hall, CB # 7411, Chapel Hill, NC 27599. E-mail: [email protected].
